Clinical Trial Update: Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma (aRCC) Receiving Systemic First-line (1st Line) Anti-cancer Treatment Under Daily Routine in Germany: Retrospective Medical Chart Review (RENALISTIC Study).

View source ↗

Summary

A retrospective chart review (RENALISTIC) evaluated first-line systemic treatment patterns and clinical outcomes in German patients with advanced renal cell car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Renal Cell | Status: TERMINATED | Results posted: 2025-01-20